Education
About Us
Working with TipRanks
Follow Us
Judy Olian Insider Profile
4 Followers
Judy Olian, Director at Ares Management, holds 4.45K shares in United Therapeutics (Ticker: UTHR), holds 29.73K shares in Ares Management (Ticker: ARES), holds 50.70K shares in Mattel (Ticker: MAT).
Profitable Transactions
5 out of 11 Profitable Transactions
Average Return
-5.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Judy Olian holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 13, 2018 - Jun 13, 2019
Return:+28.00%
The most profitable trade made by Judy Olian
Judy Olian's Trading History
Ares Management
Feb 24, 2026
Director
Uninformative Buy
59.73K
$3.21M
Mattel
May 28, 2025
Director
Uninformative Buy
130.09K
$760.56K
United Therapeutics
Mar 16, 2026
Director
Uninformative Sell
107.09K
$2.34M
List of latest transactions for each holding click on a transaction to see Judy Olian's performance on stock
You May Also Like
Judy Olian insider profile FAQ
What is the percentage of profitable transactions made by Judy Olian?
The percentage of profitable transactions made by Judy Olian is 45%.
What is the average return per transaction made by Judy Olian?
The average return per transaction made by Judy Olian is -5.80%.
What stocks does Judy Olian hold?
Judy Olian holds: ARES, MAT, UTHR stocks.
What was Judy Olian’s latest transaction?
Judy Olian latest transaction was an Uninformative Sell of $107.09K.
What was Judy Olian's most profitable transaction?
Judy Olian’s most profitable transaction was an Informative Sell of UTHR stock on June 13, 2018. The return on the trade was 28.00%.
What is Judy Olian's role in Ares Management?
Judy Olian's role in Ares Management is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.